Toll Free: 1-888-928-9744
Published: Mar, 2015 | Pages:
140 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Cellceutix Corporation - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Cellceutix Corporation - Product Pipeline Review - 2015', provides an overview of the Cellceutix Corporation's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Cellceutix Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Cellceutix Corporation including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Cellceutix Corporation's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Cellceutix Corporation's pipeline products Reasons to buy - Evaluate Cellceutix Corporation's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Cellceutix Corporation in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Cellceutix Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Cellceutix Corporation and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Cellceutix Corporation - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Explore the dormant and discontinued projects of Cellceutix Corporation and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of table 5 List of Figures 5 Cellceutix Corporation Snapshot 6 Cellceutix Corporation Overview 6 Key Information 6 Key Facts 6 Cellceutix Corporation - Research and Development Overview 7 Key Therapeutic Areas 7 Cellceutix Corporation - Pipeline Review 13 Pipeline Products by Stage of Development 13 Pipeline Products - Monotherapy 14 Cellceutix Corporation - Pipeline Products Glance 15 Cellceutix Corporation - Clinical Stage Pipeline Products 15 Cellceutix Corporation - Early Stage Pipeline Products 17 Cellceutix Corporation - Drug Profiles 21 brilacidin 21 Kevetrin 23 KM-133 26 CTIX-1278 28 CTIX-1807 29 KM-277 30 KM-278 31 KM-3174 32 KM-362 33 KM-391 34 KM-732 36 PMX-0196 37 PMX-0231 38 PMX-0243 40 PMX-10072 41 PMX-10098 42 PMX-1207 43 PMX-1241 44 PMX-1278 45 PMX-1405 46 PMX-1408 47 PMX-1502 48 PMX-20005 49 PMX-207 50 PMX-225 51 PMX-496 52 PMX-504 53 PMX-519 54 PMX-611 55 PMX-647 56 PMX-835 57 PMX-100 58 PMX-10070 59 PMX-1014 60 PMX-1045 61 PMX-1056 62 PMX-1057 63 PMX-1090 64 PMX-1091 65 PMX-1094 66 PMX-1099 67 PMX-1102 68 PMX-1142 69 PMX-1363 70 PMX-1424 71 PMX-1442 72 PMX-1445 73 PMX-1467 74 PMX-1488 75 PMX-1533 76 PMX-1547 77 PMX-1555 78 PMX-1560 79 PMX-1570 80 PMX-1572 81 PMX-1573 82 PMX-1576 83 PMX-1591 84 PMX-1625 85 PMX-183 86 PMX-223 87 PMX-229 88 PMX-247 89 PMX-255 90 PMX-30016 91 PMX-30024 92 PMX-520 93 PMX-633 94 PMX-668 95 PMX-693 96 PMX-70004 97 PMX-728 98 PMX-741 99 PMX-843 100 PMX-868 101 Cellceutix Corporation - Pipeline Analysis 102 Cellceutix Corporation - Pipeline Products by Target 102 Cellceutix Corporation - Pipeline Products by Route of Administration 103 Cellceutix Corporation - Pipeline Products by Molecule Type 104 Cellceutix Corporation - Pipeline Products by Mechanism of Action 105 Cellceutix Corporation - Recent Pipeline Updates 106 Cellceutix Corporation - Dormant Projects 132 Cellceutix Corporation - Locations And Subsidiaries 133 Head Office 133 Appendix 134 Methodology 134 Coverage 134 Secondary Research 134 Primary Research 134 Expert Panel Validation 134 Contact Us 134 Disclaimer 135
List of Tables Cellceutix Corporation, Key Information 11 Cellceutix Corporation, Key Facts 11 Cellceutix Corporation - Pipeline by Indication, 2015 13 Cellceutix Corporation - Pipeline by Stage of Development, 2015 18 Cellceutix Corporation - Monotherapy Products in Pipeline, 2015 19 Cellceutix Corporation - Phase II, 2015 20 Cellceutix Corporation - Phase I, 2015 21 Cellceutix Corporation - Preclinical, 2015 22 Cellceutix Corporation - Discovery, 2015 24 Cellceutix Corporation - Pipeline by Target, 2015 107 Cellceutix Corporation - Pipeline by Route of Administration, 2015 108 Cellceutix Corporation - Pipeline by Molecule Type, 2015 109 Cellceutix Corporation - Pipeline Products by Mechanism of Action, 2015 110 Cellceutix Corporation - Recent Pipeline Updates, 2015 111 Cellceutix Corporation - Dormant Developmental Projects,2015 137
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.